BlackRock’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.4M Buy
6,476,606
+540,852
+9% +$1.79M ﹤0.01% 2938
2025
Q1
$17.2M Sell
5,935,754
-62,844
-1% -$182K ﹤0.01% 2996
2024
Q4
$21.4M Buy
5,998,598
+175,521
+3% +$625K ﹤0.01% 2975
2024
Q3
$29M Buy
5,823,077
+368,334
+7% +$1.83M ﹤0.01% 2763
2024
Q2
$14.2M Buy
5,454,743
+4,109,867
+306% +$10.7M ﹤0.01% 3127
2024
Q1
$5.73M Buy
1,344,876
+866,857
+181% +$3.69M ﹤0.01% 3559
2023
Q4
$966K Sell
478,019
-1,949
-0.4% -$3.94K ﹤0.01% 4193
2023
Q3
$734K Buy
479,968
+73,666
+18% +$113K ﹤0.01% 4260
2023
Q2
$670K Buy
406,302
+46,644
+13% +$77K ﹤0.01% 4318
2023
Q1
$410K Buy
359,658
+1,943
+0.5% +$2.22K ﹤0.01% 4494
2022
Q4
$323K Sell
357,715
-16,163
-4% -$14.6K ﹤0.01% 4638
2022
Q3
$437K Buy
373,878
+2,162
+0.6% +$2.53K ﹤0.01% 4672
2022
Q2
$237K Sell
371,716
-4,801
-1% -$3.06K ﹤0.01% 4902
2022
Q1
$983K Buy
376,517
+28,151
+8% +$73.5K ﹤0.01% 4582
2021
Q4
$1.35M Buy
348,366
+17,420
+5% +$67.7K ﹤0.01% 4492
2021
Q3
$1.44M Sell
330,946
-20,068
-6% -$87.5K ﹤0.01% 4383
2021
Q2
$1.39M Sell
351,014
-1,005,386
-74% -$3.99M ﹤0.01% 4342
2021
Q1
$7.05M Buy
1,356,400
+50,562
+4% +$263K ﹤0.01% 3716
2020
Q4
$6.99M Buy
1,305,838
+35,764
+3% +$191K ﹤0.01% 3481
2020
Q3
$6.17M Sell
1,270,074
-155,732
-11% -$756K ﹤0.01% 3391
2020
Q2
$6.93M Buy
1,425,806
+1,214,344
+574% +$5.9M ﹤0.01% 3321
2020
Q1
$463K Buy
211,462
+7,217
+4% +$15.8K ﹤0.01% 4000
2019
Q4
$1.19M Sell
204,245
-166,473
-45% -$969K ﹤0.01% 3894
2019
Q3
$1.18M Sell
370,718
-10,953
-3% -$34.8K ﹤0.01% 3869
2019
Q2
$1.6M Sell
381,671
-420,085
-52% -$1.76M ﹤0.01% 3798
2019
Q1
$5.54M Buy
801,756
+159,956
+25% +$1.11M ﹤0.01% 3336
2018
Q4
$4.04M Buy
641,800
+170,396
+36% +$1.07M ﹤0.01% 3435
2018
Q3
$8.25M Buy
+471,404
New +$8.25M ﹤0.01% 3292